October 2025 – Sequana Medical NV (Euronext Brussels: SEQUA (the “Company” or “Sequana Medical”), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer ...
A 31-year-old Belfast resident was almost on the verge of dying after she ignored a urinary tract infection, which led to ...
A new WHO report reveals that antibiotics failed in one in six bacterial infections globally, with resistance to key drugs ...